|
Match
|
Document |
Document Title |
|
|
7619002 |
Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
The use of polyunsaturated fatty acids of the ω-3 series such as eicosapentaenoic acid (EPA, C 20 :5 ω-3), docosahexaenoic acid (DHA, C 22 :6 ω-3), or their pharmaceutically acceptable...
|
|
|
7612111 |
Esterified fatty acid composition
The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and...
|
|
|
7595341 |
Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue...
|
|
|
7585856 |
Resolvins: Biotemplates for novel therapeutic interventions
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
|
|
|
7585460 |
Method for inhibiting the biological acidification of water in contact with materials containing sulfur
The invention relates to a method for inhibiting the biological acidification of water which is in contact with materials containing sulfur in reduced form or with elemental sulfur, susceptible to...
|
|
|
7579494 |
Prevention of neutrophil recruitment
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
|
|
|
7560486 |
Composition and method for modifying the fatty acid composition of cell membranes of organs and tissues
The present invention relates to a composition and method for rapidly modifying the fatty acid composition of cell membranes of organs and tissues, in particular to increase the amount of omega-3...
|
|
|
7560484 |
Vaccine preparation containing fatty acid as a constituent
The present invention provides an adjuvant that is a hydroxy unsaturated fatty acid or a derivative thereof, as well as a vaccine preparation containing the adjuvant as a constituent. For example,...
|
|
|
7553871 |
Fatty acid antimicrobial
The novel antimicrobial composition is disclosed including from about 60 to 95% of a lipophilic polar solvent such as propylene glycol, ethylene glycol, or isopropanol and from about 0.5 to 5% of a...
|
|
|
7553870 |
Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events
The use of polyunsaturated fatty acids of the ω-3 series such as eicosapentaenoic acid (EPA, C 20:5 ω-3), docosahexaenoic acid (DHA, C 22:6 ω-3), or their pharmaceutically acceptable...
|
|
|
7547730 |
Activators of peroxisome proliferator-activated receptors
Activators of peroxisome proliferator-activated receptors comprising a polyprenyl compound, preferably (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapen
taenoic acid, as an active...
|
|
|
7531574 |
Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids
This invention provides methods for improving reproductive performance of lactating dairy cows and other mammals. The method in the case of cows comprises feeding to the cows, a composition...
|
|
|
7514472 |
Fat or oil composition
Described is a fat or oil composition which comprises at least 35 wt % of a diacylglycerol, the constituent fatty acids of said diacylglycerol satisfying the following equation: (an amount of a...
|
|
|
7514096 |
Triacylglycerols of enriched CLA content
Novel acylglycerides are disclosed comprising mono-, di- and triacylglycerides characterized by predominantly containing the conjugated linoleic acids t9,c11- and c10,t12 octadecadienoic acids to...
|
|
|
7501136 |
Deodorant composition
Provided is a deodorant composition containing (A) an extract of a plant selected from phellodendron ( Phellodendron amurense or P. chinensis ), ginkgo ( Ginkgo biloba ), Lithospermum...
|
|
|
7479286 |
Dietary lipids for improving skin and coat of pets
A source of dietary lipids containing anti-microbial fatty acids is added to a food composition intended for improving or maintaining the skin health and/or coat quality in a pet by preventing or...
|
|
|
7473708 |
Agents with leukotriene B4-like antiviral (enveloped RNA) activities
The present invention relates to the use of the antiviral activity of exogenous leukotriene B 4 (LTB 4 ), variants and derivatives thereof as a therapeutic agent in viral infections caused by...
|
|
|
7462643 |
Essential fatty acids in the prevention of cardiovascular events
The invention concerns the use of essential fatty acids with a high content in eicosapentaenoic acid ethyl ester (EPA) or docosahexaenoic acid ethyl ester (DHA) or a high concentration mixture...
|
|
|
7452548 |
Conjugated linoleic acid compositions
Novel compositions containing conjugated linoleic acids are efficacious as animal feed additives and human dietary supplements. Linoleic acid is converted to its conjugated forms in which the...
|
|
|
7439267 |
Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy
The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential...
|
|
|
7414077 |
Therapeutic intervention to mimic the effect of caloric restriction
Methods are provided for promoting longevity and decreasing the incidence of ageing associated pathologies (e.g. cancer) by the administration of one or more of the following LFFA: linoleic, oleic,...
|
|
|
7413759 |
Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
Methods for enhancing cognitive ability in infants are shown. The methods comprise feeding infants baby-food compositions containing docosahexaenoic acid (DHA) in an amount of at least about 0.5 mg...
|
|
|
7378444 |
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue...
|
|
|
7378443 |
Fatty acid analogues for the treatment of cancer
A fatty acid analogue of the general formula: R 1 -[x i -CH 2 ] n —COOR 2 , wherein R 1 is: a C 2 -C 24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C 2...
|
|
|
7358278 |
Cellular phosphorylation potential enhancing compositions preparation and use thereof
A pharmaceutical composition comprising as an active phosphorylation potential enhancing substance a pharmaceutically-acceptable salt of an alpha-keto carboxylic acid thereof alone or in...
|
|
|
7323187 |
Impregnation method
The invention relates to a method for impregnating, incorporating or surface-treating substances/articles that can be microbially decomposed, contaminated and/or infested with parasites and/or that...
|
|
|
7318930 |
Control methods for boring bark beetles
A composition which causes adult boring bark beetles to discontinue boring, discontinue laying eggs and become disoriented and bore out of the tree or cease boring altogether and die is described....
|
|
|
7304089 |
Preparation for improved dietary utilisation
Food, feed or drug preparations are described that contain conjugated trans/cis-octadecatrienoic acid, and processes are described for their production. Inventive preparations preferably comprise...
|
|
|
7265154 |
Valproic acid and derivatives thereof as histone deacetylase inhibitors
The present invention relates to the use of the drug valproic acid and derivatives thereof as inhibitors of enzymes having histone deacetylase activity. The invention also relates to the use of...
|
|
|
7241741 |
Methods and compositions for the treatment of asthma and related disorders
The present invention provides methods for the treatment of respiratory tract mucositis in individuals in need of such treatment, the method comprising the systemic administration to the individual...
|
|
|
7230029 |
Fatty acid analogues for the treatment of proliferative skin disorders
The present invention relates to fatty acid analogues of the general formula (I): R 1 -[x i -CH 2 ] n —COOR 2 wherein R 1 is; a C 1 –C 24 alkene with one or more double bonds and/or with one...
|
|
|
7226916 |
Preparation for the prevention and/or treatment of vascular disorders
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
fraction a) consisting of long chain...
|
|
|
7208522 |
Methods and compositions for the prevention and treatment of Syndrome X
Methods and compositions for preventing or treating Syndrome X are provided. The method includes administering a therapeutically effective amount of conjugated linoleic acid.
|
|
|
7202276 |
Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction...
|
|
|
7196065 |
Enteral formulation
A formulation for enteral administration to a patient is disclosed.
|
|
|
7182963 |
Cosmetic and dermopharmaceutical compositions for skin prone to acne
The invention relates to the use of an extract of olive leaves ( Olea europaea ) which is titrated in oleanolic acid and which may or may not be associated with a Larrea divaricata extract which...
|
|
|
7179842 |
Method of treating non-insulin dependent diabetes mellitus with phytanic acid derivatives
The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired...
|
|
|
7179479 |
Mosquito repellent isolated from Foeniculum vulgare fruit
The present invention relates to an insect repellent isolated from Foeniculum vulgare fruit, and more particularly, to an insect repellent comprising one or more compounds selected from the group...
|
|
|
7163960 |
Treatment and prevention of inflammatory disorders
The invention relates to methods of treating and preventing disorders associated with elevated TNF-α and/or IL-1β by administering therapeutic amounts of stearidonic acid. Further provided are...
|
|
|
7163950 |
Surfactants as malarial chloroguine resistance reversal agents
According to the first aspect of the invention, a composition for reversing malarial resistance to quinolines is disclosed. The composition includes a surfactant, such as nonylphenolethoxylate...
|
|
|
7157496 |
Prophylactic agent of hypertension containing a conjugated fatty acid as an effective ingredient and the use thereof
The objects of this invention are to prevent or ameliorate hypertension to improve physical constitution and finally to provide feeds, drinks, foods, health food supplements and pharmaceuticals...
|
|
|
7150884 |
Composition for inhibition of microbial growth
The present invention relates to compositions including peroxyacetic acid and peroxyoctanoic acid and methods for preventing microbial growth in aqueous streams including the step of applying a...
|
|
|
7141554 |
Method of treating irritable bowel syndrome
A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and...
|
|
|
7132451 |
Inhibition of TNF-α-initiated neutrophil response
The impact of lipoxin A 4 (LXA 4 ) and aspirin-triggered-lipoxins (ATL) was investigated in tumor necrosis factor (TNFα)-initiated neutrophil (PMN) responses in vitro and in vivo using...
|
|
|
7132448 |
High concentration topical insecticide containing insect growth regulator
A topical insecticide is provided which can be safe to use and avoids many common deleterious side effects of conventional topical insecticides. The insecticide contains an insecticide and an...
|
|
|
7122578 |
Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are...
|
|
|
7119118 |
Highly purified ethyl EPA and other EPA derivatives for treatment of huntington's disease
A pharmaceutical preparation comprising EPA in an appropriately assimilable form where of all the fatty acids present in the preparation at least 90%, and preferably at least 95%, is in the form of...
|
|
|
7112609 |
Nutritional supplements
The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved...
|
|
|
7101914 |
Isomer enriched conjugated linoleic acid compositions
Compositions and methods of using conjugated linoleic acid preparations enriched for the t10,c12 and c9,t11 isomers are disclosed. It is found that preparations of conjugated linoleic acid...
|
|
|
7097859 |
Indium supplement compositions and methods therefor
A tablet for oral administration of nutritional indium comprises about 10–50 mg indium sulfate, about 4–20 mg caffeine, about 2–10% by weight cocoa powder, and about 5–10% by weight ethyl...
|